What is JBIO's retained earnings?

JBIO (JBIO) reported retained earnings of -$214.76M in Q1 2026.

How has JBIO's retained earnings changed year-over-year?

JBIO's retained earnings increased by 8.8% year-over-year, from -$235.57M to -$214.76M.

What is the long-term trend for JBIO's retained earnings?

Over 5 years (2020 to 2025), JBIO's retained earnings has grown at a 67.0% compound annual growth rate (CAGR), from -$13.41M to -$174.39M.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

JBIO JBIO Retained Earnings

Retained Earnings at other companies

Vertex PharmaceuticalsVRTX

$14.59B+42.3%

Travere Therapeutics, Inc.TVTX

-$1.51B-1.4%

Vera TherapeuticsVERA

-$881.9M-71.9%

AnaptysBio, Inc.ANAB

-$825.44M-3.4%

Avalo TherapeuticsAVTX

-$468.15M-22.1%

Cullinan Therapeutics, Inc.CGEM

-$637.78M-53.0%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's retained earnings?: JBIO (JBIO) reported retained earnings of -$214.76M in Q1 2026.
How has JBIO's retained earnings changed year-over-year?: JBIO's retained earnings increased by 8.8% year-over-year, from -$235.57M to -$214.76M.
What is the long-term trend for JBIO's retained earnings?: Over 5 years (2020 to 2025), JBIO's retained earnings has grown at a 67.0% compound annual growth rate (CAGR), from -$13.41M to -$174.39M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.